Best Life Sciences Companies in Phoenix, United States

Provider of a neurological disease diagnostic tool for providers. The company has developed a diagnostic kit called Syn-One Test which assists in the diagnosis of synucleinopathy in patients. The kit is a skin biopsy tool that has the ability to detect and visualize abnormal skin cell conditions based on pathological evidence.

Funding rounds

• May 2025Series A$13.5M
• Apr 2025Grant (prize money)$2.4M
• Feb 2025Series A$8.6M
• Mar 2024Seed$2M

Founders & team

Roy FreemanCo-FounderChristopher GibbonsCo-FounderTodd LevineCo-Founder & CMO

Investors

Top Corner Capital, NIH, Honor Health, HHS, Tanis Ventures, Trianacapitalpartners

Tech stack

Anime.JsAutoptimizeCart FunctionalityCore-JsGodaddyGoogle Analytics

AI-powered electronic quality management system for life science companies. It enhances the CAPA process by guiding quality teams through establishing and maintaining compliant CAPA procedures. It automates documentation, revision management, and reporting. It helps life sciences companies streamline quality processes, reduce regulatory risks, and bring products to market.

Funding rounds

• Apr 2024Series B$17.5M
• Jul 2022Series B$23M

Founders & team

Doron SitbonFounder & CEO

Investors

Israel Growth Partners, Vertex Ventures, TPY Capital, Vertex Ventures Israel

Tech stack

CloudflareCloudflare Bot ManagementCookieyesCore-JsGenesis BlocksGodaddy

Developer of a pan-cancer detection blood test. This DNA-based test dynamically adapts to identify unique epigenetic fingerprints from a patient's tumor, irrespective of cancer type. The technology detects gene silencing events through methylation, regardless of location in the genome. Applications include earlier diagnosis, monitoring of residual or recurrent disease, and assessing treatment efficacy. The goal is to provide a broad-spectrum diagnostic tool to improve patient outcomes.

Funding rounds

• Sep 2024Grant (prize money)$990.8K
• Sep 2023Grant (prize money)$398K

Founders & team

Mitesh BoradCo-FounderAbhijit PatelCo-FounderMichael BarrettCo-Founder & CEO

Investors

HHS

Developer of small molecule-based therapeutics for the treatment of inflammatory skin diseases. The company's lead product candidate DMVT-505 is a therapeutic AhR modulating agent inhibiting several proinflammatory factors used for the treatment of psoriasis, atopic dermatitis. Other products of the company include DMVT-502 against atopic dermatitis and vitiligo which is Phase 1 clinical trial, DMVT-504 against primary focal hyperhidrosis.

Funding rounds

• Jun 2021Series D$160M
• Jun 2021Conventional Debt$40M

Founders & team

Todd ZavodnickCEO

Investors

Marathon Asset Management, NovaQuest Capital Management

Provider of oncolytic virus-based immunotherapeutics. The company is developing oncolytic immunotherapies based on the myxoma virus (MYXV) platform to maintain an immune response and treat cancer. Their therapeutic pipeline includes both monotherapies and therapies to be used in combination with immune checkpoint blockade and other immuno-modulatory approaches.

Developer of surgical scalpels for hospital & doctors use. The company has developed smart medical tools that help in healing, reduces infections, increases wound strength with less scarring, less pain, and provide solutions for nerve damages by using planatome technology.

Funding rounds

• Oct 2023Series A$5M
• Oct 2023Convertible Debt$1M

Founders & team

Tim TobinCEO

Stem-cell based therapeutics for male and female reproductive health. Its lead product Caverstem is an autologous stem cell-based therapeutic for the treatment of erectile dysfunction. In addition, it also stem cell treatments for male infertility and female sexual dysfunction,

At-home muscle strengthening therapy for lasting knee pain relief. They offer clinically proven solutions for knee pain relief, providing advanced at-home therapy. Their e-vive product demonstrates a commitment to quality care and innovation in the orthopedics field. They focus on improving patient outcomes through accessible and effective muscle strengthening programs. They operate in the healthcare sector, providing a direct-to-consumer model for their therapy. They are dedicated to helping individuals achieve lasting relief from knee pain and improve their overall quality of life.

Funding rounds

• Feb 2020Series A$2.1M
• May 2019Series A$4M
• Sep 2018Series A$3M
• Jun 2016Series A$5.6M

Founders & team

Struan ColemanCo-Founder

Investors

RCT, California Technology Ventures, Aphelion Capital

Integrated biomechanics, imaging, and electrophysiology tools for in vitro research. The company provides innovative solutions for replicating in vivo cellular environments in controlled in vitro settings. They offer all-in-one systems and stand-alone modules for electrophysiology, mechanics, and imaging, including flexible and stretchable multi-electrode arrays (MEAs), glass MEAs, 3D-MEAs, and microfluidics. Their products support applications like neuroprotective drug screening, alternatives to animal testing, cell culture, and cardiac action potentials. The company aims to improve the predictive accuracy of pre-clinical research by combining biomechanics and electrophysiology in a dynamic 3D environment, delivering more relevant and reliable data. They offer tools for cell stretching, imaging, and recording/stimulating electrophysiological activity, separately or concurrently. Their stretchable MEAs allow manipulation of chemical, electrical, and mechanical factors independently. The company focuses on providing accurate data, efficient workflows, and unrivaled results to better predict clinical outcomes and reduce failure rates in clinical trials.

Funding rounds

• Sep 2022Grant (prize money)$2.1M
• Sep 2021Grant (prize money)$474.6K
• Jan 2020Grant (prize money)$15K
• Oct 2018Grant (prize money)—

Founders & team

Oliver GraudejusFounder & CEO

Investors

Invest Southwest, MassChallenge, HHS

Pioneering sports medicine solutions, optimizing patient care through innovation and integration. This company is a leader in sports medicine, providing surgeons with comprehensive and manageable solutions. Their portfolio integrates with leading-edge technologies and a continuum of care in joint preservation, optimizing patient care throughout their medical journey. They offer pioneering products for rotator cuff repair, shoulder labral repair, biceps repair, AC joint repair, hand & wrist, ACL reconstruction, knee instrumentation, meniscus repair, and hip procedures. Their offerings include all-suture anchors, knotless anchors, biocomposite anchors, suture passers, and arthroscopy systems. They also provide capital equipment, biologics, and solutions for ASCs and trauma cases. They offer medical education and resources for healthcare professionals, as well as patient resources through a dedicated patient recovery site.

Neolight is a medical device company that develops phototherapy beds to treat jaundice in pre-term and full-term babies. It is portable, uses LED technology, and consists of four modular plug-and-play blocks. The company is also developing a disposable mattress that babies can sleep on for the device.

Exsomed develops orthopedic implants for hand and wrist. Products developed by the company include ArcPhix (compression screw indicated for use in the surgical fixation of small bones, bone fragments, and osteotomies. It is not indicated for soft tissue fixation), ArrowPhix (tapered design for functional fusion at angles 0°-25°), and Intramedullary Threaded Nail (cannulated screw system intended for fixation of intra-articular and extra-articular fractures and non-unions of small bones and small bone fragments, arthrodesis of small joints, bunionectomy and osteotomies). The company has received FDA clearance for its ITN Cannulated Screw System.